The impact of COVID-19 infection on the live birth rate in fresh embryo transfer cycles - Scorecard - MDSpire

The impact of COVID-19 infection on the live birth rate in fresh embryo transfer cycles

  • By

  • Dan Sun

  • Lu Wang

  • Ying Su

  • Ni Jin

  • Juan Zhou

  • Ling Li

  • Yan Zhang

  • Xiaohong Wang

  • Huishou Zhao

  • Shuqiang Chen

  • Ying Ju

  • April 17, 2026

  • 0 min

Share

Clinical Scorecard: Effects of COVID-19 Infection on Live Birth Rates in Fresh Embryo Transfer Cycles

At a Glance

CategoryDetail
ConditionImpact of COVID-19 infection on assisted reproductive technology (ART) outcomes
Key MechanismsSARS-CoV-2 infects reproductive tissues via ACE2 receptors expressed in ovaries, testes, oocytes, granulosa cells, blastocysts, uterus, and placenta
Target PopulationPatients undergoing fresh embryo transfer (fET) cycles in IVF treatment
Care SettingAssisted reproduction centers performing IVF and fresh embryo transfer cycles

Key Highlights

  • COVID-19 infection is associated with a significantly lower live birth rate (LBR) in fresh embryo transfer cycles (adjusted OR 0.655)
  • Infections occurring 28–84 days before oocyte retrieval with fever ≥ 38.5°C markedly reduce LBR (OR 0.467)
  • Dual-partner COVID-19 infection significantly reduces LBR compared to uninfected controls (OR 0.591)

Guideline-Based Recommendations

Diagnosis

  • Routine SARS-CoV-2 nucleic acid or antigen testing every other day during IVF treatment cycles
  • Stratify patients by infection timing, fever presence, and partner infection status

Management

  • Consider postponing fresh embryo transfer cycles if COVID-19 infection occurred within 28–84 days prior to oocyte retrieval with fever ≥ 38.5°C
  • Evaluate risks carefully in couples with dual-partner infection before proceeding with IVF
  • Follow ASRM and related societies' recommendations to suspend new treatment cycles in infected patients unless delay poses health risks

Monitoring & Follow-up

  • Monitor pregnancy outcomes including live birth rates and miscarriage rates in COVID-19 infected patients undergoing fET
  • Use logistic regression analyses to assess impact of infection timing and severity on outcomes

Risks

  • Increased mid-to-late miscarriage rates in COVID-19 infected patients (adjusted OR 7.929)
  • Potential adverse impact on embryo implantation and pregnancy success related to infection timing and fever
  • Uncertainty remains; larger multicenter studies needed to validate findings

Patient & Prescribing Data

Women undergoing fresh embryo transfer cycles with or without COVID-19 infection

COVID-19 infection, especially with fever and dual-partner infection, is linked to reduced live birth rates; treatment timing and infection status should inform clinical decisions

Clinical Best Practices

  • Perform thorough COVID-19 screening and documentation prior to and during IVF cycles
  • Delay fresh embryo transfer if recent COVID-19 infection with fever occurred within critical window (28–84 days before oocyte retrieval)
  • Consider partner infection status as a factor in IVF cycle planning
  • Balance risks and benefits of proceeding with IVF in infected patients according to current evidence and guidelines
  • Employ propensity score matching or similar methods to control confounding factors in outcome assessments

Related Resources & Content

Original Source(s)

Related Content